These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21810856)

  • 1. Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegaly.
    Ciganoka D; Balcere I; Kapa I; Peculis R; Valtere A; Nikitina-Zake L; Lase I; Schiöth HB; Pirags V; Klovins J
    Eur J Endocrinol; 2011 Oct; 165(4):517-25. PubMed ID: 21810856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.
    Filopanti M; Ronchi C; Ballarè E; Bondioni S; Lania AG; Losa M; Gelmini S; Peri A; Orlando C; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4824-8. PubMed ID: 15914528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary Adenoma:
    Gedvilaite-Vaicechauskiene G; Kriauciuniene L; Tamasauskas A; Rovite V; Mandrika I; Wu SN; Huang CW; Poskiene L; Liutkeviciene R
    Medicina (Kaunas); 2024 Aug; 60(8):. PubMed ID: 39202532
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival.
    Li D; Tanaka M; Brunicardi FC; Fisher WE; Gibbs RA; Gingras MC
    Cancer; 2011 Jul; 117(13):2863-72. PubMed ID: 21692047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
    Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.
    Zhou G; Gingras MC; Liu SH; Li D; Li Z; Catania RL; Stehling KM; Li M; Paganelli G; Gibbs RA; Demayo FJ; Fisher WE; Brunicardi FC
    World J Surg; 2011 Aug; 35(8):1715-24. PubMed ID: 21249361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of transmission of novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene in patients with autism.
    Lauritsen MB; Nyegaard M; Betancur C; Colineaux C; Josiassen TL; Kruse TA; Leboyer M; Ewald H
    Am J Med Genet B Neuropsychiatr Genet; 2003 Aug; 121B(1):100-4. PubMed ID: 12898583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
    Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
    J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder.
    Nyegaard M; Børglum AD; Bruun TG; Collier DA; Russ C; Mors O; Ewald H; Kruse TA
    Mol Psychiatry; 2002; 7(7):745-54. PubMed ID: 12192619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.
    Syro LV; Sundsbak JL; Scheithauer BW; Toledo RA; Camargo M; Heyer CM; Sekiya T; Uribe H; Escobar JI; Vasquez M; Rotondo F; Toledo SP; Kovacs K; Horvath E; Babovic-Vuksanovic D; Harris PC
    Pituitary; 2012 Sep; 15(3):342-9. PubMed ID: 21744088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced irisin levels in patients with acromegaly.
    Sendur SN; Baykal G; Firlatan B; Aydin B; Lay I; Dagdelen S; Alikasifoglu M; Erbas T
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):251-261. PubMed ID: 35851444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
    Corbetta S; Ballaré E; Mantovani G; Lania A; Losa M; Di Blasio AM; Spada A
    Eur J Clin Invest; 2001 Mar; 31(3):208-14. PubMed ID: 11264647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR.
    Taboada GF; Luque RM; Neto LV; Machado Ede O; Sbaffi BC; Domingues RC; Marcondes JB; Chimelli LM; Fontes R; Niemeyer P; de Carvalho DP; Kineman RD; Gadelha MR
    Eur J Endocrinol; 2008 Mar; 158(3):295-303. PubMed ID: 18299461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly.
    Gatto F; Biermasz NR; Feelders RA; Kros JM; Dogan F; van der Lely AJ; Neggers SJ; Lamberts SW; Pereira AM; Ferone D; Hofland LJ
    Eur J Endocrinol; 2016 May; 174(5):651-62. PubMed ID: 26888629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
    Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNPs of miR-23b, miR-107 and HMGA2 and their Relations with the Response to Medical Treatment in Acromegaly Patients.
    Armagan DM; Akdemir AS; Ozkaya HM; Korkmaz OP; Gazioglu N; Kadioglu P; Tanriover N; Dagistanli KF; Dirican A; Ozturk M
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):593-600. PubMed ID: 32838437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression.
    Muhammad A; Coopmans EC; Gatto F; Franck SE; Janssen JAMJL; van der Lely AJ; Hofland LJ; Neggers SJCMM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):915-924. PubMed ID: 30346538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klotho gene G395A and C1818T polymorphisms in acromegaly: Association with clinical presentation and comorbidities.
    Helvaci N; Kabacam S; Dagdelen S; Lay I; Karabulut E; Mut M; Alikasifoglu M; Erbas T
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):598-605. PubMed ID: 33296101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma).
    Yu B; Zhang Z; Song H; Chi Y; Shi C; Xu M
    Med Sci Monit; 2017 Apr; 23():1947-1955. PubMed ID: 28434012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly.
    Wassenaar MJ; Biermasz NR; Pereira AM; van der Klaauw AA; Smit JW; Roelfsema F; van der Straaten T; Cazemier M; Hommes DW; Kroon HM; Kloppenburg M; Guchelaar HJ; Romijn JA
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4671-8. PubMed ID: 19864451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.